| Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia DL Rolnik, D Wright, LC Poon, N O’Gorman, A Syngelaki, ... New England Journal of Medicine 377 (7), 613-622, 2017 | 2092 | 2017 |
| Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study RWK Chiu, R Akolekar, YWL Zheng, TY Leung, H Sun, KCA Chan, ... Bmj 342, 2011 | 1131 | 2011 |
| Procedure‐related risk of miscarriage following amniocentesis and chorionic villus sampling: a systematic review and meta‐analysis R Akolekar, J Beta, G Picciarelli, C Ogilvie, F D'Antonio Ultrasound in Obstetrics & Gynecology 45 (1), 16-26, 2015 | 865 | 2015 |
| Analysis of cell‐free DNA in maternal blood in screening for fetal aneuploidies: updated meta‐analysis MM Gil, MS Quezada, R Revello, R Akolekar, KH Nicolaides Ultrasound in obstetrics & gynecology 45 (3), 249-266, 2015 | 727 | 2015 |
| Competing risks model in early screening for preeclampsia by biophysical and biochemical markers R Akolekar, A Syngelaki, L Poon, D Wright, KH Nicolaides Fetal diagnosis and therapy 33 (1), 8-15, 2013 | 722 | 2013 |
| Prediction of early, intermediate and late pre‐eclampsia from maternal factors, biophysical and biochemical markers at 11–13 weeks R Akolekar, A Syngelaki, R Sarquis, M Zvanca, KH Nicolaides Prenatal diagnosis 31 (1), 66-74, 2011 | 696 | 2011 |
| First-trimester prediction of hypertensive disorders in pregnancy LCY Poon, NA Kametas, N Maiz, R Akolekar, KH Nicolaides Hypertension 53 (5), 812-818, 2009 | 674 | 2009 |
| Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation N O’Gorman, D Wright, A Syngelaki, R Akolekar, A Wright, LC Poon, ... American journal of obstetrics and gynecology 214 (1), 103. e1-103. e12, 2016 | 651 | 2016 |
| Noninvasive prenatal diagnosis of fetal trisomy 18 and trisomy 13 by maternal plasma DNA sequencing EZ Chen, RWK Chiu, H Sun, R Akolekar, KCA Chan, TY Leung, P Jiang, ... PloS one 6 (7), e21791, 2011 | 493 | 2011 |
| Competing risks model in screening for preeclampsia by maternal characteristics and medical history D Wright, A Syngelaki, R Akolekar, LC Poon, KH Nicolaides American journal of obstetrics and gynecology 213 (1), 62. e1-62. e10, 2015 | 480 | 2015 |
| ASPRE trial: performance of screening for preterm pre‐eclampsia DL Rolnik, D Wright, LCY Poon, A Syngelaki, N O'Gorman, ... Ultrasound in obstetrics & gynecology 50 (4), 492-495, 2017 | 463 | 2017 |
| Screening for pre‐eclampsia by maternal factors and biomarkers at 11–13 weeks' gestation MY Tan, A Syngelaki, LC Poon, DL Rolnik, N O'Gorman, JL Delgado, ... Ultrasound in Obstetrics & Gynecology 52 (2), 186-195, 2018 | 356 | 2018 |
| Metformin versus placebo in obese pregnant women without diabetes mellitus A Syngelaki, KH Nicolaides, J Balani, S Hyer, R Akolekar, R Kotecha, ... New England Journal of Medicine 374 (5), 434-443, 2016 | 349 | 2016 |
| Maternal serum placental growth factor at 11+ 0 to 13+ 6 weeks of gestation in the prediction of pre‐eclampsia R Akolekar, E Zaragoza, LCY Poon, S Pepes, KH Nicolaides Ultrasound in Obstetrics and Gynecology: The Official Journal of the …, 2008 | 345 | 2008 |
| Size-based molecular diagnostics using plasma DNA for noninvasive prenatal testing SCY Yu, KCA Chan, YWL Zheng, P Jiang, GJW Liao, H Sun, R Akolekar, ... Proceedings of the National Academy of Sciences 111 (23), 8583-8588, 2014 | 342 | 2014 |
| Comparison of diagnostic accuracy of early screening for pre‐eclampsia by NICE guidelines and a method combining maternal factors and biomarkers: results of SPREE MY Tan, D Wright, A Syngelaki, R Akolekar, S Cicero, D Janga, M Singh, ... Ultrasound in Obstetrics & Gynecology 51 (6), 743-750, 2018 | 335 | 2018 |
| A competing risks model in early screening for preeclampsia D Wright, R Akolekar, A Syngelaki, LCY Poon, KH Nicolaides Fetal diagnosis and therapy 32 (3), 171-178, 2012 | 318 | 2012 |
| Risk of miscarriage following amniocentesis or chorionic villus sampling: systematic review of literature and updated meta‐analysis LJ Salomon, A Sotiriadis, CB Wulff, A Odibo, R Akolekar Ultrasound in Obstetrics & Gynecology 54 (4), 442-451, 2019 | 317 | 2019 |
| Prediction of gestational diabetes mellitus by maternal factors and biomarkers at 11 to 13 weeks S Nanda, M Savvidou, A Syngelaki, R Akolekar, KH Nicolaides Prenatal diagnosis 31 (2), 135-141, 2011 | 300 | 2011 |
| Diagnosis of fetal non‐chromosomal abnormalities on routine ultrasound examination at 11–13 weeks' gestation A Syngelaki, A Hammami, S Bower, V Zidere, R Akolekar, KH Nicolaides Ultrasound in Obstetrics & Gynecology 54 (4), 468-476, 2019 | 281 | 2019 |
